ConSynance Therapeutics
PrivateLast Round
Grant
Apr 15, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ConSynance Therapeutics is a biopharmaceutical company that develops treatments for central nervous system diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ConSynance Therapeutics Comparables
Compare ConSynance Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EPM Group Inc. | 78% | |
| Saniona AB | 78% | |
| Aardark Therapeutics | 77% |
ConSynance Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 15, 2026 | ||||
| Divestiture | Aug 9, 2021 |
ConSynance Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foundation for Prader-Willi Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 220% MoM.
- Apr 15, 2026
Received grant from Foundation for Prader-Willi Research.
ConSynance Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ConSynance Therapeutics's valuation, stock price, and market status.
Is ConSynance Therapeutics a public or private company?
ConSynance Therapeutics is a private company.
What is the current stock price of ConSynance Therapeutics?
ConSynance Therapeutics is a private company, so its shares have no public market price. Caplight tracks ConSynance Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ConSynance Therapeutics worth (valuation)?
Valuation information for ConSynance Therapeutics is not publicly available.
Can I buy ConSynance Therapeutics stock?
ConSynance Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ConSynance Therapeutics's last funding round?
ConSynance Therapeutics's most recent funding round was Grant on April 15, 2026.
Who are the main investors in ConSynance Therapeutics?
Key investors in ConSynance Therapeutics include Foundation for Prader-Willi Research.
Will ConSynance Therapeutics IPO soon?
No public IPO plans have been announced for ConSynance Therapeutics.
How can I track ConSynance Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in ConSynance Therapeutics's shares on secondary markets.